Clinical trial
CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to…
NCT00482521 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00482521 |
|---|---|
| Title | CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment |
| Official title | A Phase I, Open-Label Study to Determine the Maximum Tolerated Dose (MTD) and to Evaluate the Safety Profile of CC-4047 in Subjects With Advanced Solid Tumors |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | CC-4047 |
| Enrollment | 42 |
| Start date | Mar 1, 2007 |
| Primary completion | Sep 1, 2010 |
| Completion | Aug 1, 2012 |
| First posted | Jun 5, 2007 |
| Last update posted | Aug 28, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: